or Try an Advanced Search...

    Protein Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    EXEL B Exelixis, Inc. -6.54
    PBYI D Puma Biotechnology Inc -2.37
    PRLD D Prelude Therapeutics Incorporated -1.06
    NTBL F Notable Labs, Ltd. -0.65
    DCPH A Deciphera Pharmaceuticals, Inc. 0.36
    AVBP D ArriVent BioPharma, Inc. 1.03
    DAWN A Day One Biopharmaceuticals, Inc. 3.45
    BPMC A Blueprint Medicines Corporation 3.85
    ELVN A Enliven Therapeutics, Inc. 4.08
    CRIS A Curis, Inc. 4.17
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biopharmaceutical Tyrosine Kinase Receptors Tyrosine Kinase Cancer Treatment Non Small Cell Lung Cancer Solid Tumors Antineoplastic Drugs Biotechnology Blastoma Breast Cancer Chronic Myeloid Leukemia Drugs Gastrointestinal Gastrointestinal Stromal Tumor Glioblastoma Glioblastoma Multiforme Her2 Lung Cancer Lymphoma

    Related ETFs - A few ETFs which own one or more of the above listed Protein Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    CNCR C Loncar Cancer Immunotherapy ETF 9.09
    IDNA C iShares Genomics Immunology and Healthcare ETF 6.34
    BBP C BioShares Biotechnology Products Fund 6.3
    PBE C PowerShares Dynamic Biotech & Genome 6.11
    LABD C Direxion Daily S&P Biotech Bear 3X Shares 5.18
    View all Protein Kinase Inhibitor ETFs...
    Compare ETFs
    Compare BBP to PBE Compare IDNA to LABD Compare PBE to LABD

        Protein Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
        May 1 BPMC Blueprint Medicines Q1 2024 Earnings Preview
        May 1 EXEL Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
        May 1 EXEL Q1 2024 Exelixis Inc Earnings Call
        May 1 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
        May 1 EXEL Exelixis (EXEL) Q1 2024 Earnings Call Transcript
        May 1 EXEL Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript
        Apr 30 EXEL Exelixis down 7% as Q1 financial results disappoint
        Apr 30 EXEL Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say
        Apr 30 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts
        Apr 30 EXEL Exelixis Non-GAAP EPS of $0.17 misses by $0.12, revenue of $425.2M misses by $35.27M
        Apr 30 EXEL Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
        Apr 30 BPMC Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
        Apr 30 DCPH ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
        Apr 30 CRIS Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
        Apr 30 DCPH Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
        Apr 29 EXEL Exelixis Q1 2024 Earnings Preview
        Apr 29 DCPH Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
        Apr 29 DCPH Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 DCPH Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biopharmaceutical Tyrosine Kinase Receptors Tyrosine Kinase Cancer Treatment Non Small Cell Lung Cancer Solid Tumors Antineoplastic Drugs Biotechnology Blastoma Breast Cancer Chronic Myeloid Leukemia Drugs Gastrointestinal Gastrointestinal Stromal Tumor Glioblastoma Glioblastoma Multiforme Her2 Lung Cancer Lymphoma
        Protein Kinase Inhibitor

        Protein kinase inhibitors are drugs that block the activity of one or more protein kinases. Protein kinases are enzymes that add phosphate groups to proteins, which can alter their activity and function. Protein kinase inhibitors are used to treat a variety of diseases, including cancer, inflammation, and autoimmune disorders.

        Browse All Tags